IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.265
EU - Europa 6.391
AS - Asia 4.605
SA - Sud America 3.012
AF - Africa 277
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 1
Totale 23.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.126
BR - Brasile 2.492
UA - Ucraina 1.656
SG - Singapore 1.468
VN - Vietnam 1.004
RU - Federazione Russa 976
IE - Irlanda 816
DE - Germania 740
DK - Danimarca 625
HK - Hong Kong 575
SE - Svezia 525
TR - Turchia 432
IT - Italia 428
CN - Cina 419
FI - Finlandia 350
KR - Corea 325
AR - Argentina 212
MA - Marocco 130
GB - Regno Unito 117
ID - Indonesia 103
EC - Ecuador 101
BD - Bangladesh 58
CO - Colombia 56
MX - Messico 55
IN - India 54
PY - Paraguay 49
EU - Europa 47
ZA - Sudafrica 47
IQ - Iraq 43
CA - Canada 42
AT - Austria 38
CI - Costa d'Avorio 27
CL - Cile 26
PE - Perù 26
FR - Francia 25
VE - Venezuela 23
UY - Uruguay 21
PL - Polonia 20
PK - Pakistan 19
EG - Egitto 17
TN - Tunisia 17
JP - Giappone 16
KE - Kenya 14
AL - Albania 13
BE - Belgio 12
NL - Olanda 12
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
KZ - Kazakistan 9
UZ - Uzbekistan 9
JO - Giordania 8
CZ - Repubblica Ceca 7
ES - Italia 7
AZ - Azerbaigian 6
BO - Bolivia 6
GT - Guatemala 6
LB - Libano 6
OM - Oman 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AM - Armenia 5
JM - Giamaica 5
BG - Bulgaria 4
BH - Bahrain 4
NP - Nepal 4
SA - Arabia Saudita 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CR - Costa Rica 3
HN - Honduras 3
IL - Israele 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
SV - El Salvador 3
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
GN - Guinea 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BS - Bahamas 1
CH - Svizzera 1
EE - Estonia 1
GA - Gabon 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PR - Porto Rico 1
Totale 23.591
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.628
Fairfield 1.006
Dublin 816
Boardman 661
Singapore 628
Ashburn 614
Hong Kong 575
Wilmington 494
Dallas 469
Ho Chi Minh City 410
Woodbridge 406
Houston 379
Seattle 352
San Mateo 330
Lawrence 328
Princeton 328
Chandler 305
Cambridge 288
Centro 276
Moscow 209
São Paulo 196
Hanoi 183
New York 165
Ann Arbor 164
San Diego 136
Des Moines 134
Hefei 127
Beijing 84
Rio de Janeiro 77
Los Angeles 71
Curitiba 51
Haiphong 43
Porto Alegre 43
Belo Horizonte 42
Brasília 42
Guayaquil 38
Chicago 37
The Dalles 37
Nuremberg 36
Biên Hòa 33
Munich 33
Saint Petersburg 33
Salvador 32
Campinas 30
Ribeirão Preto 29
Quito 28
Thái Bình 28
Abidjan 27
Da Nang 27
London 27
Sorocaba 23
Norwalk 21
Shanghai 21
São Bernardo do Campo 21
Turku 21
Guangzhou 20
Guarulhos 20
Manaus 20
Phủ Lý 18
Goiânia 17
Hải Dương 17
Jakarta 17
Lima 17
Thái Nguyên 17
Vienna 17
Asunción 16
Duque de Caxias 16
Ninh Bình 16
Warsaw 16
Buenos Aires 15
Osasco 15
Salt Lake City 15
Santo André 15
Brooklyn 14
Buffalo 14
Juiz de Fora 14
Montevideo 14
Nova Iguaçu 14
Baghdad 13
Cape Town 13
Ha Long 13
Ipatinga 13
Itaquaquecetuba 13
Johannesburg 13
Jundiaí 13
Praia Grande 13
São José dos Campos 13
Tokyo 13
Volta Redonda 13
Atlanta 12
Brussels 12
Bắc Ninh 12
Fortaleza 12
Joinville 12
Kilburn 12
Nairobi 12
Bogotá 11
Bragança Paulista 11
Can Tho 11
Caxias do Sul 11
Totale 13.287
Salva come PNG Salva come JPEG
Nome #
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 155
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 143
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 142
[Closed surgical treatment in acute severe pancreatitis] 136
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 131
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 131
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 127
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 121
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 120
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 119
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 119
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 116
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 114
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 112
Ultrasonography of the pancreas. 7. Intraoperative imaging. 111
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 109
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 109
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 108
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 108
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study. 106
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 106
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 104
B-Cell Lymphoma Presenting as Acute Pancreatitis. 103
A systematic review on robotic pancreaticoduodenectomy. 103
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 102
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 101
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 101
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 100
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 99
Enhanced recovery pathways in pancreatic surgery: State of the art 99
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 98
A preoperative score to predict early death after pancreatic cancer resection 97
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 97
Italian consensus guidelines for chronic pancreatitis 96
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 96
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 96
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 95
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 93
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 91
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 91
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 91
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 90
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 90
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 90
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 87
Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications 87
Neuroendocrine Tumor Disease- An Evolving Landscape. 86
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 86
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 86
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 86
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 85
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 85
Current status of robotic distal pancreatectomy: a systematic review. 85
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 85
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 84
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 84
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 84
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 84
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 83
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 83
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 83
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 83
Allelotype of pancreatic acinar cell carcinoma. 83
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 83
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 83
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 82
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis 81
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 81
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 81
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 81
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 80
Anastomotic leakage in pancreatic surgery. 80
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 80
Well-differentiated pancreatic nonfunctioning tumors/carcinoma 80
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 80
Pancreas: Insulinoma--new insights into an old disease. 79
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 79
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 79
Questions about branch-duct IPMNs with Sendai negative criteria. 79
Pancreatoblastoma in adults: a review of the literature. 78
Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study. 78
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 78
Pancreatic enzyme replacement therapy after gastric resection: An update 78
Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. 77
Imaging of neuroendocrine gastroenteropancreatic tumours 77
Rectal indomethacin to prevent post-ERCP pancreatitis. 77
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 77
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 77
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 76
Pancreatic abscess and other pus-harboring collections related to pancreatitis: a review of 108 cases 76
Enucleation of pancreatic neoplasms. 76
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. 76
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 76
The role of 18fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer. 76
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 76
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 75
Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma. 75
Identification of a novel antibody associated with autoimmune pancreatitis 75
La chemioterapia loco-egionale migliora la sopravvivenza dei pazienti affetti da adenocarcinoma pancreatico non resecabile? Risultati di uno studio aperto, controllato 75
Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. 75
Totale 9.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.298 0 0 0 0 0 272 378 307 395 331 400 215
2021/20222.074 123 565 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/20266.069 498 1.145 1.202 2.765 358 101 0 0 0 0 0 0
Totale 23.667